These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 12901345
21. [Diagnosis and therapy of polycythemia vera in the era of JAK2]. Lengfelder E. Dtsch Med Wochenschr; 2013 Feb; 138(7):331-6. PubMed ID: 23393003 [Abstract] [Full Text] [Related]
22. Polycythemia vera: a review. Golden C. Clin J Oncol Nurs; 2003 Feb; 7(5):553-6. PubMed ID: 14603552 [Abstract] [Full Text] [Related]
23. Risk-adapted therapy in essential thrombocythemia and polycythemia vera. Finazzi G, Barbui T. Blood Rev; 2005 Sep; 19(5):243-52. PubMed ID: 15963833 [Abstract] [Full Text] [Related]
24. Polycythemia vera-associated pruritus and its management. Saini KS, Patnaik MM, Tefferi A. Eur J Clin Invest; 2010 Sep; 40(9):828-34. PubMed ID: 20597963 [Abstract] [Full Text] [Related]
25. Contemporary approach to essential thrombocythemia and polycythemia vera. Aruch D, Mascarenhas J. Curr Opin Hematol; 2016 Mar; 23(2):150-60. PubMed ID: 26717193 [Abstract] [Full Text] [Related]
26. [Polycythemia vera and pregnancy: difficulties for diagnosis and treatment]. Deruelle P, Bouhassoun J, Trillot N, Jude B, Ducloy AS, Subtil D. Gynecol Obstet Fertil; 2005 May; 33(5):331-7. PubMed ID: 15878688 [Abstract] [Full Text] [Related]
27. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases]. Sánchez Fayos J, Prieto E, Román A, Soto de Ozaeta C, Nevado I, Richart A, Chica E, Loscertales J, Calabuig T, Benítez J, Outeiriño J. Sangre (Barc); 1996 Dec; 41(6):447-57. PubMed ID: 9148422 [Abstract] [Full Text] [Related]
28. Risk factors and prevention of vascular complications in polycythemia vera. Barbui T, Finazzi G. Semin Thromb Hemost; 1997 Dec; 23(5):455-61. PubMed ID: 9387204 [Abstract] [Full Text] [Related]
36. Acute leukemia in polycythemia vera. Landaw SA. Semin Hematol; 1976 Jan; 13(1):33-48. PubMed ID: 766188 [Abstract] [Full Text] [Related]
37. Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera. Benevolo G, Marchetti M, Melchio R, Beggiato E, Sartori C, Biolé CA, Rapezzi D, Bruno B, Milan A. Vasc Health Risk Manag; 2023 Jan; 19():765-778. PubMed ID: 38025519 [Abstract] [Full Text] [Related]
39. Long-term effects of the treatment of polycythemia vera with recombinant interferon-alpha. Silver RT. Cancer; 2006 Aug 01; 107(3):451-8. PubMed ID: 16804923 [Abstract] [Full Text] [Related]
40. [Postpolycythemic myeloid metaplasia in patients with polycythemia vera]. Spasojević J, Pejin D, Stajnic S. Med Pregl; 1997 Aug 01; 50(5-6):224-8. PubMed ID: 9297056 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]